Hygrovest Limited (AU:HGV) has released an update.
Hygrovest Limited, an Australian investment company, has struck a deal to sell its stake in Emerging Therapeutics Group Pty Ltd, with the transaction including an upfront cash payment and a follow-up amount, totaling slightly below the investment’s carrying value but well above its acquisition cost. This move marks a strategic shift for Hygrovest’s portfolio toward greater diversification and liquidity. The sale was facilitated by HD Capital Partners and underscores the company’s medium-term goal of capital growth for its shareholders.
For further insights into AU:HGV stock, check out TipRanks’ Stock Analysis page.
